Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALLERGAN PLC

(AGN)
  Report
SummaryNewsRatingsCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Allergan plc entered into a definitive agreement to acquire Soliton, Inc. for approximately $510 million.

05/10/2021 EST

Allergan plc entered into a definitive agreement to acquire Soliton, Inc. (NasdaqCM:SOLY) for approximately $510 million on May 8, 2021. Allergan will fund the purchase price from cash, cash equivalents, and available borrowing capacity under existing credit facilities. Under the terms of agreement, Allergan will pay $22.6 per share in cash for each outstanding share of Soliton. In case of termination by Soliton, a fee of $18.625 million will be paid to Allergan and if agreement is terminated by Allergan, a fee of $20 million will be paid to Soliton. The transaction is subject to customary closing conditions, including clearance by the U.S. antitrust authorities under the Hart-Scott-Rodino Act and approval of Soliton's shareholders. The transaction has been unanimously approved by the Boards of Directors of Allergan and Soliton. The consummation of the merger is not conditioned upon AbbVie?s receipt of financing. On November 7, 2021, AbbVie delivered notice to extend the date by which either party has a right to terminate the merger agreement if the consummation of the merger has not occurred from November 8, 2021 to February 8, 2022. in connection with delivery of the First Extension Notice, AbbVie made a payment to Soliton in the amount of $11,500,000. The transaction is expected to close in the second half of 2021. Guggenheim Securities, LLC acted as financial advisor and fairness opinion provider to Soliton. Joseph E. Gilligan and Leslie B. Reese of Hogan Lovells US LLP and Charles D. Vaughn and Aileen L. Nagy of Nelson Mullins Riley & Scarborough LLP acted as legal advisors to Soliton. Eric L. Schiele and Maggie D. Flores of Kirkland & Ellis LLP acted as legal advisors to Allergan. Saratoga Proxy Consulting, LLC is acting as the proxy solicitor to Soliton for a fee of approximately $40,000. Soliton will pay a fee of $13.675 million to Guggenheim Securities, of which a cash milestone fee of $1,000,000 became payable upon the rendering of Guggenheim Securities? opinion.


© S&P Capital IQ 2021
All news about ALLERGAN PLC
11/19Allergan Aesthetics to Present Data from its Aesthetic Portfolio at the 2021 American S..
CI
10/27Allergan, an AbbVie Company, to Present New Data on Investigational AGN-190584 for the ..
AQ
10/26Allergan, an AbbVie Company, to Present New Data on Investigational AGN-190584 for the ..
CI
10/05HAGENS BERMAN : Law Firm Investigating Permanent Injuries and Disfigurement from Botched C..
BU
07/30ABBVIE : Allergan - FDA Approves Expanded BOTOX Label to Include Eight New Muscles to Trea..
AQ
07/21ABBVIE : Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfo..
AQ
05/10Allergan plc entered into a definitive agreement to acquire Soliton, Inc. for approxima..
CI
04/16STAMP DUTY BATTLE : Abbvie Wins Appeal Against €587m Irish Stamp Duty
AQ
04/01Allergan Aesthetics Launches SkinMedica® Neck Correct Cream
CI
03/16GLOBAL MARKETS LIVE: Alibaba, Nokia, Berkshire Hathaway…
More news
Analyst Recommendations on ALLERGAN PLC
More recommendations
Financials (USD)
Sales 2020 15 208 M - -
Net income 2020 - - -
Net Debt 2020 - - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 63 649 M 63 649 M -
Capi. / Sales 2020 4,19x
Capi. / Sales 2021 4,02x
Nbr of Employees 17 400
Free-Float 99,9%
Income Statement Evolution
Managers and Directors
Robert A. Michael President & Director
Scott Reents Director
Ryan Quigley Director
Andres Rodrigo Director
Basil Blakeney Director
Sector and Competitors
1st jan.Capi. (M$)
ALLERGAN PLC0.97%63 659
JOHNSON & JOHNSON4.42%432 641
ROCHE HOLDING AG20.68%329 493
PFIZER, INC.39.64%288 501
NOVO NORDISK A/S73.12%256 630
ELI LILLY AND COMPANY45.17%221 499